businesspress24.com - SynCardia Selected as a Finalist for the 2012 MEDTEC Europe Innovation Awards
 

SynCardia Selected as a Finalist for the 2012 MEDTEC Europe Innovation Awards

ID: 1076803

Freedom(R) Portable Driver for Powering SynCardia's Total Artificial Heart Shortlisted for "Most Innovative Cardiac Product of the Year"

(firmenpresse) - TUCSON, AZ -- (Marketwire) -- 01/26/12 -- SynCardia Systems, Inc. (), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that it has been nominated for one of the most prestigious awards in the European medical device industry.

The Freedom® portable driver, the world's first wearable power supply for the , has been shortlisted for "Most Innovative Cardiac Product of the Year" as part of the MEDTEC European Medical Device Technology (EMDT) Innovation Awards. The Awards are the only European awards dedicated to recognizing achievements in the medical device sector.

"These awards are regarded as a universal benchmark of quality within the medical-device industry," said , SynCardia CEO/President. "Being shortlisted is a tremendous achievement. The Freedom portable driver has been pivotal in the Total Artificial Heart becoming the new standard of care for end-stage biventricular heart failure."

Weighing approximately 6 kg (13.5 lbs), the Freedom portable driver allows stable Total Artificial Heart patients to be discharged from the hospital to enjoy life at home while they wait for a matching donor heart. The Freedom driver is CE approved for use in Europe and undergoing an in the U.S. More than 70 patients worldwide have been supported by the Freedom driver, accounting for more than 24 years of patient support.

This year's winners will be announced on March 14, 2012, at a special ceremony during MEDTEC Europe 2012, in the Atrium of the Messe Stuttgart in Stuttgart, Germany.

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart...

Like SynCardia on
Follow SynCardia on Twitter -
Connect with SynCardia on

Image Available:



Don Isaacs




SynCardia Systems

520-955-0660


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Paycor Releases Infographic on Payroll and Tax Deductions
SEI Revamps Managed Accounts Program: Decreases Fees, Doubles Manager Lineup
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 26.01.2012 - 08:05 Uhr
Sprache: Deutsch
News-ID 1076803
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

TUCSON, AZ


Phone:

Kategorie:

Venture Capital


Anmerkungen:


Diese Pressemitteilung wurde bisher 139 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"SynCardia Selected as a Finalist for the 2012 MEDTEC Europe Innovation Awards
"
steht unter der journalistisch-redaktionellen Verantwortung von

SynCardia Systems, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von SynCardia Systems, Inc.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 91


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.